This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Yan Y Degenhardt: Innovator in Antigen Binding Proteins
Introduction
Yan Y Degenhardt is a prominent inventor based in Collegeville, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. With a total of 2 patents, her work focuses on innovative solutions for treating diseases mediated by CD96.
Latest Patents
Degenhardt's latest patents include compositions for treating CD96 mediated diseases. These antigen binding proteins are designed to provide new therapeutic options for patients suffering from related conditions. Her research emphasizes the importance of targeted treatments in modern medicine.
Career Highlights
Degenhardt is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where she continues to advance her research and development efforts. Her work has been instrumental in pushing the boundaries of what is possible in the realm of antigen binding technologies.
Collaborations
Throughout her career, Degenhardt has collaborated with notable colleagues, including Jun Guan and Kenneth William Hance. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their shared field of expertise.
Conclusion
Yan Y Degenhardt stands out as a key figure in the development of antigen binding proteins, contributing valuable insights and advancements in biotechnology. Her work not only reflects her dedication to innovation but also highlights the potential for new treatments in medicine.